NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
DLA CIO: Securing AI Pipelines Is Now a Core Mission
With small vendors comprising most of its supplier base, Roberts says stronger oversight and zero-trust controls are critical to counter cyber threats.
6m watch -
Health IT Leaders Eye AI, Data Sharing to Improve Affordability
Healthy policy leaders say smarter data use, streamlined workflows and transparent AI tools could help lower costs and improve patient care.
3m read -
How to Thrive in Cybersecurity Without Burning Out
Explore mental health in cybersecurity including imposter syndrome, burnout, boundaries and building a sustainable career in high-pressure tech environments.
34m watch -
Project ARIA Pushes AI From Concept to Soldier-Ready Capability
Army CTO Gabe Chiulli explains how Project ARIA is accelerating AI adoption, cutting red tape and delivering tools to soldiers at speed.
20m watch
